Abstract
Intraductal papillary growth of mucin producting hypersecreting, columnar cells characterizes a group of rare pancreatic exocrine neoplasms which we propose to call intraductal papillary-mucinous tumors (IPMT). We analysed the histopathology of 26 IPMT in relation to gastro-enteropancreatic marker expression, genetic changes and biology. Four IPMT showing only mild dysplasia were considered to be adenomas. Nine tumours displayed moderate dysplasia and were regarded as borderline. Severe dysplasia-carcinoma in situ changes were found in 13 IPMT which were therefore classified as intraductal carcinomas. Six of these carcinomas were frankly invasive and two of these had lymph node metastases. The invasive component resembled mucinous noncystic carcinoma in all but one tumour which showed a ductal invasion pattern. Immunohistochemically, an intestinal marker type was found in most carcinomas, while gastric type differentiation prevailed among adenomas or borderline tumours. K-ras mutations (seven at codon 12 and one at codon 13) were found in 31% of IPMT (2 adenomas, 1 borderline, 5 carcinomas). Nuclear p53 overexpression was detected in 31% of IPMT (6 carcinomas and 2 borderline IPMT) and correlated with p53 mutations (one at exon 8 and the other at exon 5) in two carcinomas. p53 abnormalities were unrelated to K-ras mutation. c-erbB-2 overexpression was observed in 65% of IPMT, with various grades of dysplasia. Twenty-two of 24 patients are alive and well after a mean post-operative follow-up of 41 months. Only two patients, both with invasive cancer at the time of surgery, died of tumour disease. It is concluded that pancreatic IPMT encompass neoplasms which, in general, have a favorable prognosis, but are heterogeneous in regard to grade of dysplasia and marker expression. Adenoma, borderline tumour, intraductal carcinoma and invasive carcinoma can be differentiated. p53 changes but not K-ras mutation or c-erbB-2 overexpression are related to the grade of malignancy. Most IPMT differ in histological structure, marker expression and behaviour from ductal adenocarcinoma.
Similar content being viewed by others
References
Almoguerra C, Shibata D, Forrester K, Martin Arnheim N, Perucho M (1988) Most human carcinomas of the pancreas contain mutant c-K-ras genes. Cell 53:549–554
Bara J, Gautier R, Daher N, Zaghouani H, Decaens C (1986) Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosa. Cancer Res 46:3983–3989
Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G, Theis B, Russel RCG, Neoptolemos J, Williamson RCN, Lane DP, Lemoine NR (1991) Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 64:1076–1082
Bastid C, Bernard JP, Sarles H, Payan MJ, Sahel J (1991) Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis. Pancreas 6:15–22
Compagno J, Oertel JE (1978) Mucinous cystic neoplasms with overt and latent malignancy (cystoadenocarcinoma). A clinicopathologic study of 41 cases. Am J Clin Pathol 69:573–580
Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd series, fasc. 19. Armed Forces Institute of Pathology, Washington
Ferrari BT, O'Halloran RL, Longmire WP, Lewin KJ (1979) Atypical papillary hyperplasia of the pancreatic duct mimicking obstructing pancreatic carcinoma. N Engl J Med 301:531–532
Fiocca R, Villani L, Tenti, Solcia E, Cornaggia M, Frigerio B, Capella C (1987) Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. Pathol Res Pract 182:308–325
Fiocca R, Villani L, Tenti P, Cornaggia M, Finzi G, Riva C, Capella C, Bara J, Samloff IM, Solcia E (1990) The foveolar cell component of gastric cancer. Hum Pathol 21:260–270
Furukawa T, Takahashi T, Kobari M, Matsuno S (1992) The mucus-hypersecreting tumor of the pancreas. Cancer 70:1505–1513
Furuta F, Watanabe H, Ikeda S (1992) Differences between solid and duct-ectatic types of pancreatic ductal carcinoma. Cancer 69:1327–1333
Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR (1990) The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 161:195–200
Hsu SM, Raine L, Franger H (1981) Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577–580
Itai Y, Kokubo T, Atomi Y, Kuroda A, Haraguti Y, Terano A (1987) Mucin-hypersecreting carcinoma of the pancreas. Radiology 165:51–55
Jupp RA, Richards AD, Kay J, Dunn BM, Wyckoff J, Samloff IM, Yamamoto K (1988) Identification of the aspartic proteinase from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin. Eur Biochem J 254:895–898
Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele H-G, Honold G, Pantel K, Riethmüller G, Scherer E, Maurer J, Maacke H, Deppert W (1993) p53 and K-ras alterations in pancreatic epithelial cell lesions. Oncogene 8:289–298
Klöppel G (1984) Pancreatic non-endocrine tumors. In: Klöppel G, Heitz Ph (eds) Pancreatic pathology. Churchill Livingstone, Edinburgh, pp. 207–220
Klöppel G (1993) Pathology of nonendocrine pancreatic tumors. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds) The pancreas. Biology, pathobiology and disease. 2nd edn, Raven Press, New York, pp. 871–897
Lan MS, Finn OJ, Fernsten P, Metzgar RS (1985) Isolation and properties of human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res 45:305–310
Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Klöppel G (1992) K-Ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102:230–236
Marchal G, Vernette M, Roustan J, Henry G (1974) Papillomatose biliare cancerisée avec atteinte de l'ampoule de Vater et du canal de Wirsung. Hépatectomie gauche élargie et duodeno-pancréatectomie en un temps. J Chir (Paris) 107:555–578
Milchgrub S, Campuzano M, Casillas J, Albores-Saavedra J (1992) Intraductal adenocarcinoma of the pancreas. Cancer 69:651–656
Mizumoto K, Inagaki T, Koizumi M, Uemera M, Ogawa M, Kitazawa S, Tsutsumi M, Toyokawa M, Konishi Y (1988) Early pancreatic duct adenocarcinoma. Hum Pathol 19:242–244
Morohoshi T, Kanda M, Asanuma K, Klöppel G (1989) Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 64:1329–1335
Morohoshi T, Kunimura T, Kanda M, Takahashi H, Yagi H, Shimizu K, Nakayoshi A, Asanuma K (1990) Multiple carcinomata associated with anomalous arrangement of the biliary and pancreatic duct system. A report of two cases with a literature survey. Acta Pathol Jpn 40:755–763
Nardelli J, Bara J, Rosa B, Burtin P (1983) Intestinal metaplasia and carcinomas of the human stomach. A immunohistological study. J Histochem Cytochem 31:366–375
Nishihara K, Fukuda T, Tsuneyoshi M, Kominami T, Maeda S, Saku M (1993) Intraductal papillary neoplasm of the pancreas. Cancer 72:689–696
Obara T, Saitoh Y, Maguchi H, Ura H, Yokota KI, Okamura K, Namiki M (1992) Papillaary adenoma of the pancreas with excessive mucin secretion. Pancreas 7:114–117
Obara T, Saitoh Y, Maguchi H, Ura H, Kitazawa S, Koike Y, Okamura K, Namiki M (1992) Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. Hum Pathol 23:82–85
Ohashi K, Takagi K (1980) ERCP and imaging diagnosis of pancreatic cancer. Gastroenterol Endosc 77:1493–1495
Payan MJ, Werri L, Moncada K (1990) Villous adenoma of the main pancreatic duct: A potentially malignant tumor? Am J Gastroenterol 85:459–463
Pellegata NS, Losekon M, Fodde R, Pugliese V, Saccomanno S, Renault B, Bernini LF, Ranzani GN (1992) Detection of K-ras mutations by denaturating gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Anticancer Res 12:1731–1736
Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN (1994) K-ras and p53 gene mutations in pancreatic cancer: ductal and non-ductal tumors progress through different genetic lesions. Cancer Res 54:1556–1560
Prat M, Rossino P, Bussolati G, Morra I, Comoglio PM (1987) Production of monoclonal antibodies for the immunohistochemical detection of gastric carcinomas. Cancer Detec Prev 10:293–301
Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC (1991) p53 expression in colorectal tumors. Am J Pathol 138:807–813
Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Meera Khan P, Ranzani GN (1993) Base transitions are the most frequent genetic change on p53 in gastric cancer. Cancer Res 53:2614–2617
Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schroder S, Wurbs D, Klöppel G (1991) Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients. Gastroenterology 101:512–519
Rogers PN, Seywright MM, Murray WR (1987) Diffuse villous adenoma of the pancreatic duct. Pancreas 2:727–730
Samloff IM, Liebman WM (1973) Cellular localization of group II pepsinogens in humans stomach and duodenum by immunofluorescence. Gastroenterology 79:36–42
Satoh K, Sasano H, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Kobayashi N, Okano T, Toyota T, Sawai T (1993) An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 72:51–56
Satoh K, Sawai T, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Toyota T (1993) The point mutation of c-Ki-ras at codon 12 in carcinoma of the head region and in intraductal mucin-hypersecreting neoplasm of the pancreas. Int J Pancreatol 2:135–143
Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534–1543
Scarpa A, Capelli P, Zamboni G, Oda T, Mukai K, Bonetti F, Martignoni G, Iacono C, Serio G, Hirohashi S (1993) Neoplasia of the ampulla of Vater. K-ras and p53 mutations. Am J Pathol 142:1163–1172
Sessa F, Bonato M, Frigerio B, Capella C, Solcia S, Prat M, Bara J, Samloff IM (1990) Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98:1655–1665
Sessa F, Bonato M, Kindl S, Rosso R, Carnevali L (1991) Immunocytochemical detection of C-Neu oncogene on inflammed and neoplastic pancreas. Lab Invest 64:95A
Smith VTHB, Boot AJ, Smiths AA, Fluren GJ, Cornelisse CJ, Bos JL (1988) K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16:7773–7782
Stommer P, Gebhardt C, Schultheiss KH (1990) Adenocarcinomas of the pancreas with a prominent intraductal component: a special variety of ductal adenocarcinoma. Pancreas 5:114–118
Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y (1993) The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 3:237–244
Tada M, Omata M, Ohoto M (1991) Ras gene mutations in intraductal papillary neoplasms of the pancreas. Cancer 67:634–637
Vojtesek B, Bartek J, Midgley CA, Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. J Immunol Methods 151:237–244
Warshaw AL, Berry J, Gang DL (1987) Villous adenoma of the duct of Wirsung. Dig Dis Sci 32:1311–1314
Yamada M, Kozuka S, Yamao K, Nakazawa S, Naitoh Y, Tsukamoto Y (1991) Mucin-producing tumor of the pancreas. Cancer 68:159–168
Yamaguchi K, Tanaka M (1991) Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papilla. Am J Gastroenterol 86:835–839
Yamanaka Y, Friess H, Kobrin MS, Büchler M, Kunz J, Beger HG, Korc M (1993) Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol 24:1127–1134
Yanagisawa A, Kato Y, Ohtake K, Ohashi I, Hori M, Takagi K, Sugano H (1991) c-K-ras point mutations in duct ectatictype mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 82:1057–1060
Yanagisawa A, Ohtake K, Ohashi K, Hori K, Kitagawa T, Sugano H, Kato Y (1993) Frequent c-K-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res 53:953–956
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sessa, F., Solcia, E., Capella, C. et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Vichows Archiv A Pathol Anat 425, 357–367 (1994). https://doi.org/10.1007/BF00189573
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00189573